Pharmaceutical
Manufacturing
Health

Eli Lilly

$126.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Pre-Market
$0.00 (0.00%) Pre-Market

Why Robinhood?

You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!

About

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. Read More The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Employees
38,680
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
133.81B
Price-Earnings Ratio
40.91
Dividend Yield
1.94
Average Volume
7.19M
High Today
$126.65
Low Today
$125.16
Open Price
$125.31
Volume
2.03M
52 Week High
$130.75
52 Week Low
$74.51

Collections

Pharmaceutical
Manufacturing
Health
Health And Wellness
Pharmacies
Therapy
Medical
Healthcare

News

TradingNewsNowMar 18

Latest Performance: Eli Lilly And Company (NYSE: LLY)

Eli Lilly And Company is in the healthcare sector and drug manufacturers industry. The company CEO is David A. Ricks. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. Previous Intraday Trading Performance: The LLY stock showed a previous change of 0.70% with an open at 122.97 and a close of 123.94. It reached an intraday high of 124.16...

102
InvestorPlaceMar 16

The Numbers Say Eli Lilly Stock Has Still More Upside For Investors

Shares of global pharma giant Eli Lilly (NYSE: LLY ) have performed incredibly well over the past decade, rising more than 350% as the market gained 300%. But, the LLY stock rally has kicked into overdrive during the past year.

82
InvestorPlaceMar 15

The Case Against Pfizer Stock and the Rest of the Industry

The industry line is simple: Drugs cost a lot to develop and overcharging consumers is the only way to recoup the upfront investment.

339

Earnings

$1.03
$1.19
$1.34
$1.50
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available Apr 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.